Home › Companies › CELLDEX THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and CELLDEX THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 5, 2025: 12 items on CELLDEX THERAPEUTICS INC.’s Form 8-K, filed June 6, 2025: 9 elected · 3 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CELLDEX THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CELLDEX THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Anthony S. Marucci (Chief Executive Officer) | 54,056,360 | 60,785 | 164,073 | -- | 4,031,935 | 99.8% | Elected | — |
| Elect Director: Keith L. Brownlie | 53,883,737 | 250,401 | 147,080 | -- | 4,031,935 | 99.5% | Elected | — |
| Elect Director: Cheryl L. Cohen | 53,969,213 | 165,776 | 146,229 | -- | 4,031,935 | 99.6% | Elected | — |
| Elect Director: Herbert J. Conrad | 53,051,316 | 1,082,802 | 147,100 | -- | 4,031,935 | 98% | Elected | — |
| Elect Director: Rita I. Jain, M.D. | 53,914,572 | 207,007 | 159,639 | -- | 4,031,935 | 99.6% | Elected | — |
| Elect Director: James J. Marino | 53,832,714 | 301,247 | 147,257 | -- | 4,031,935 | 99.4% | Elected | — |
| Elect Director: Garry A. Neil, M.D. | 53,900,408 | 233,807 | 147,003 | -- | 4,031,935 | 99.5% | Elected | — |
| Elect Director: Harry H. Penner, Jr. | 53,773,546 | 360,343 | 147,329 | -- | 4,031,935 | 99.3% | Elected | — |
| Elect Director: Denice Torres | 54,104,937 | 29,828 | 146,453 | -- | 4,031,935 | 99.9% | Elected | — |
| 2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 58,043,825 | 119,347 | 149,981 | -- | -- | 99.7% | Approved | — |
| 3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares | 53,158,156 | 963,067 | 159,995 | -- | 4,031,935 | 98% | Approved | — |
| Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement. | 53,482,418 | 626,666 | 172,134 | -- | 4,031,935 | 99% | Approved | — |
Source: CELLDEX THERAPEUTICS INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.
Each item below shows how the 190 asset managers that disclosed a CELLDEX THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Anthony S. Marucci
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Anthony S. Marucci (Chief Executive Officer)”): 54,056,360 for, 60,785 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,432,781 for, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Cheryl L. Cohen
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 53,969,213 for, 165,776 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,431,614 for, 1,167 against, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Denice Torres
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Denice Torres”): 54,104,937 for, 29,828 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,432,781 for, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Garry Neil, M.D.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Garry A. Neil, M.D.”): 53,900,408 for, 233,807 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,432,781 for, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Harry H. Penner, Jr.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Harry H. Penner, Jr.”): 53,773,546 for, 360,343 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,412,183 for, 20,598 against, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Mixed |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Herbert J. Conrad
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herbert J. Conrad”): 53,051,316 for, 1,082,802 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,213,534 for, 219,247 against, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,682,038 | 4,436 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,772,221 | 158,656 | 0 | 0 | Mixed |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Mixed |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: James J. Marino
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: James J. Marino”): 53,832,714 for, 301,247 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,431,614 for, 1,167 against, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Keith L. Brownlie
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Keith L. Brownlie”): 53,883,737 for, 250,401 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,432,781 for, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Rita I. Jain, M.D.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Rita I. Jain, M.D.”): 53,914,572 for, 207,007 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2026.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,432,781 for, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“3. An amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares”): 53,158,156 for, 963,067 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 0 | 496,205 | 0 | 0 | Against |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Mixed |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Fund voting reports, all 52 managers: 26,901,690 for, 531,091 against, 9,367 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kynam Capital Management, LP | 0 | 0 | 0 | 4,605,007 | Withhold |
| Eversept Partners, LP | 696,499 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 32,200 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 728,699 for, 4,605,007 withheld.
Combines 7 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 53,482,418 for, 626,666 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,011,664 | 1,146 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Fund voting reports, all 52 managers: 27,430,468 for, 2,313 against, 9,367 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 7,593,655 | 0 | 0 | 0 | For |
| Fidelity | 5,276,364 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 4,605,007 | Withhold |
| Commodore Capital LP | 3,680,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,423,800 | 0 | 0 | 0 | For |
| State Street | 2,294,666 | 1,146 | 0 | 0 | For |
| BlackRock | 1,826,084 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,609,488 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,200,000 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,188,429 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,028,947 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 812,653 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 767,389 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 696,499 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 651,061 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 550,966 | 0 | 0 | 0 | For |
| Charles Schwab | 537,844 | 0 | 0 | 0 | For |
| American Century | 523,522 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 497,270 | 0 | 0 | 0 | For |
| Nuveen | 429,126 | 0 | 0 | 0 | For |
| Northern Trust | 425,952 | 0 | 0 | 0 | For |
| Point72 | 372,070 | 0 | 0 | 0 | For |
| TFG Asset Management GP Ltd | 0 | 288,650 | 0 | 0 | Against |
| JPMorgan | 185,263 | 0 | 0 | 0 | For |
| AXA INVESTMENT MANAGERS UK Ltd | 0 | 184,803 | 0 | 0 | Against |
Institutional-manager reports, all 152 managers: 37,255,297 for, 704,387 against, 4,605,007 withheld, 125,332 abstained, 361 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025.
CELLDEX THERAPEUTICS INC.’s own tally for this item (“2. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 58,043,825 for, 119,347 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 27,431,574 for, 1,207 against, 9,367 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | Mixed |
| JPMorgan | 102,477 | 0 | 0 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 66,384,191 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 13.75% |
| 2 | Fidelity | 8.57% |
| 3 | MUTUAL FUND SERIES TRUST | 5.63% |
| 4 | T. Rowe Price | 3.80% |
| 5 | BlackRock | 2.91% |
| 6 | State Street | 1.53% |
| 7 | Charles Schwab | 0.81% |
| 8 | American Century | 0.75% |
| 9 | Hartford | 0.69% |
| 10 | TIAA | 0.64% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Wellington | 11.44% |
| 2 | Fidelity | 7.95% |
| 3 | Kynam Capital Management, LP | 6.94% |
| 4 | Commodore Capital LP | 5.54% |
| 5 | T. Rowe Price | 5.16% |
| 6 | State Street | 3.46% |
| 7 | BlackRock | 2.75% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.42% |
| 9 | Novo Holdings A/S | 1.81% |
| 10 | Woodline Partners LP | 1.79% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 12.58% | 13F |
| BlackRock | 8.32% | 13F |
| FMR (Fidelity) | 8.10% | 13F |
| FMR LLC | 7.32% | DEF14A |
| Vanguard Group | 5.87% | 13F |
| T. Rowe Price | 5.14% | 13F |
| COMMODORE CAPITAL LP | 5.05% | DEF14A |
| State Street | 4.23% | 13F |
| Point72 | 3.95% | 13F |
| Geode Capital | 2.39% | 13F |
Percentages above are of 66,384,191 shares outstanding, as reported by CELLDEX THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CELLDEX THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At CELLDEX THERAPEUTICS INC.'s shareholder meeting held June 5, 2025, in the 2024-2025 proxy season, 190 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 2,712 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — CELLDEX THERAPEUTICS INC.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CELLDEX THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.
CELLDEX THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.